Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAM Solution for Post-Operative Ileus
NCT01863407Phase 3Unknown
- Start
- Apr 2013
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone, allantoin and metronidazole in postoperative ileus (POI) (2 arms). Primary endpoint: Time to achieve recovery of both upper and lower GI function at 7 days. Status: unknown.
02
Drugs
dexamethasoneallantoinmetronidazole
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT01863407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863407.